Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2022-07-29 00:00:00 ET · period of report 2022-07-28 · accession 0000899243-22-027077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-07-29 | 2022-07-28 | BEAM | Evans John M. | CEO, Dir | S - Sale | $65.78 | -20.0K | 125.4K | -14% | -$1.32M |
| M | 2022-07-29 | 2022-07-28 | BEAM | Evans John M. | CEO, Dir | S - Sale | $65.75 | -30.0K | 1.11M | -3% | -$1.97M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-28 | S | D | 6,953 | $64.88 | 136,047 | I | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.38, inclusive. |
| 2 | Common | Common Stock | 2022-07-28 | S | D | 2,247 | $67.82 | 123,000 | I | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.72 to $68.49, inclusive. |
| 3 | Common | Common Stock | 2022-07-28 | S | D | 201 | $66.61 | 125,247 | I | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.50 to $66.61, inclusive. |
| 4 | Common | Common Stock | 2022-07-28 | S | D | 10,599 | $65.92 | 125,448 | I | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.46 to $66.45, inclusive. |
| 5 | Common | Common Stock | 2022-07-28 | S | D | 173 | $68.49 | 1,088,520 | D | — | — | |
| 6 | Common | Common Stock | 2022-07-28 | S | D | 2,848 | $67.80 | 1,088,693 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.45 to $67.87, inclusive. |
| 7 | Common | Common Stock | 2022-07-28 | S | D | 1,562 | $66.74 | 1,091,541 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.44 to $67.37, inclusive. |
| 8 | Common | Common Stock | 2022-07-28 | S | D | 15,236 | $65.82 | 1,093,103 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.43 to $66.34, inclusive. |
| 9 | Common | Common Stock | 2022-07-28 | S | D | 10,181 | $64.87 | 1,108,339 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.42, inclusive. |